Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€7.54

€7.54

-1.790%
-0.136
-1.790%
€13.67
 
04.07.25 / Tradegate WKN: 896047 / Symbol: BCRX / Name: Biocryst Pharm / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Biocryst Pharmaceuticals Stock

A loss of -1.790% shows a downward development for Biocryst Pharmaceuticals.
Biocryst Pharmaceuticals is currently one of the favorites of our community with 20 Buy predictions and no Sell predictions.
With a target price of 13 € there is a hugely positive potential of 72.41% for Biocryst Pharmaceuticals compared to the current price of 7.54 €.
So far the community has only identified positive things for Biocryst Pharmaceuticals stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Biocryst Pharmaceuticals in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
S********** s********
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Biocryst Pharmaceuticals vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Biocryst Pharmaceuticals -1.790% -5.656% -21.946% 26.171% 3.034% -26.554% 69.858%
Krystal Biotech 0.370% 2.066% 4.579% -26.369% -20.466% 95.242% -
Ardelyx Inc. -1.560% 15.019% 12.419% -25.797% -26.888% 538.073% -41.452%
Evolus Inc -0.660% -1.948% -11.176% -22.959% -28.095% -30.734% 59.283%

Comments

Prediction Buy
Perf. (%) -1.44%
Target price 12.731
Change
Ends at 01.07.26

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its price target raised by analysts at Bank of America Corporation from $13.00 to $15.00. They now have a "buy" rating on the stock.
Ratings data for BCRX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -0.82%
Target price 11.092
Change
Ends at 30.06.26

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "outperform" rating re-affirmed by analysts at Royal Bank Of Canada. They now have a $13.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -0.82%
Target price 15.358
Change
Ends at 30.06.26

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its price target raised by analysts at Wedbush from $16.00 to $18.00. They now have an "outperform" rating on the stock.
Ratings data for BCRX provided by MarketBeat
Show more